ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2160 • 2015 ACR/ARHP Annual Meeting

    The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis: A Diagnostic Accuracy and Cost-Effectiveness Study

    Raashid Luqmani1, Ellen Lee2, Surjeet Singh3, Michael Gillett2, Wolfgang A. Schmidt4, Mike Bradburn2, Bhaskar Dasgupta5,6, Andreas P Diamantopoulos7, Wulf Forrester-Barker8, William Hamilton9, Shauna Masters10, Brendan McDonald11, Eugene McNally8, Colin T. Pease12, Jennifer Piper8, John Salmon13, Allan Wailoo2, Konrad Wolfe14, Andrew Hutchings15 and TABUL Study group, 1Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 2School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom, 31Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 4Medical Center for Rheumatology and Clinical Immunology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany, 5Rheumatology, Southend University Hospital, Essex, United Kingdom, 6Southend University Hospital, Essex, United Kingdom, 7Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 8Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 9Primary Care, University of Exeter, Exeter, United Kingdom, 10Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, United Kingdom, 11Department of Neuropathology and Ocular Pathology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom, 12Rheumatology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 13Ophthalmology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom, 14Department of Pathology, Southend University Hospital, Essex, United Kingdom, 15Health Services Research Unit, London School of Hygiene and Tropical Medicine, London, United Kingdom

    Background/Purpose: Giant cell arteritis (GCA) is a relatively common form of primary systemic vasculitis which if untreated can lead to permanent sight loss. It is…
  • Abstract Number: 2161 • 2015 ACR/ARHP Annual Meeting

    Ustekinumab for the Treatment of Refractory Giant Cell Arteritis

    Richard Conway1,2, Lorraine O'Neill3,4, Eileen O'Flynn3, Geraldine M. McCarthy5,6, Conor Murphy7, Douglas J. Veale8, Ursula Fearon9 and Eamonn S. Molloy10, 1CARD Newman Research Fellow, University College Dublin, Dublin, Ireland, 2Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 3Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 4Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland, 5Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland, 6University College Dublin, Dublin, Ireland, 7Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland, 8St Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, Dublin 4, Ireland, 9St. Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, Dublin 4, Ireland, 10St Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, St Vincent's University Hospital, Dublin 4, Dublin 4, Ireland

    Background/Purpose: Giant cell arteritis (GCA) requires treatment with high dose corticosteroids. Many patients require chronic steroid therapy with associated significant side effects. There is a…
  • Abstract Number: 2162 • 2015 ACR/ARHP Annual Meeting

    Associations Between Education and Health Status Among Hispanics with Self-Reported Arthritis and/or Joint Pain

    Leigha Vilen1, Rebecca J. Cleveland2, Alfredo Rivadeneira1, Mary Altpeter3, Betsy Hackney4, Victoria Sepulveda2 and Leigh F. Callahan4, 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Institute on Aging, University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC

    Background/Purpose: Understanding the associations between education and health status among Hispanics with arthritis and/or joint pain is crucial in adapting existing arthritis interventions for this…
  • Abstract Number: 2163 • 2015 ACR/ARHP Annual Meeting

    Associations Between Sex Differences, Pain, Insomnia, and Depression in Older Adults with Osteoarthritis: A Cross-Sectional Study

    Minhui Liu1, Susan McCurry1, Michael Vitiello2, Basia Belza1 and Michael Von Korff3, 1University of Washington School of Nursing, Seattle, WA, 2Psychiatry and Behavioral Sciences, Biobehavioral Nursing and Health Systems, University of Washington School of Medicine, Seattle, WA, 3Group Health Research Institute, Seattle, WA

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis and affects nearly 30 million Americans. Chronic pain is the major symptom in OA and…
  • Abstract Number: 2164 • 2015 ACR/ARHP Annual Meeting

    Burden of Symptomatic Knee Osteoarthritis in the United States: Impact of Race/Ethnicity, Age and Sex

    Bhushan Deshpande1, Jeffrey N. Katz2, Daniel H. Solomon2, Edward H. Yelin3 and Elena Losina2, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3University of California, San Francisco, San Francisco, CA

    Background/Purpose : Growing evidence suggests that the prevalence and incidence of knee OA is rising, partially due to increasing life expectancy and the growing obesity…
  • Abstract Number: 2165 • 2015 ACR/ARHP Annual Meeting

    Awareness and Reasons for Lack of Post-Fracture Osteoporosis Therapy: A Survey of Post-Menopausal Women

    Denise Boudreau1, Onchee Yu1, Akhila Balasubramanian2, Jane Grafton1, Heidi Wirtz3, Andreas Grauer3, D. Barry Crittenden3 and Delia Scholes1, 1Group Health Research Institute, Seattle, WA, 2Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, 3Amgen Inc., Thousand Oaks, CA

    Background/Purpose: Osteoporotic fractures cause patient morbidity and increase risk for future fracture. Effective drug therapies for osteoporosis (OP) are available, yet only a minority of…
  • Abstract Number: 2166 • 2015 ACR/ARHP Annual Meeting

    Work Productivity in Newly Diagnosed, Untreated Rheumatoid Arthritis Patients

    Siri Lillegraven1, Nina P. Sundlisæter1, Anna-Birgitte Aga1, Inge C Olsen1, Till Uhlig2, Tore K. Kvien1, Espen A. Haavardsholm1 and The ARCTIC study group, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose:Rheumatoid arthritis (RA) is a known cause of work productivity loss. The goal within rheumatology today is to diagnose RA as soon as possible, to…
  • Abstract Number: 2167 • 2015 ACR/ARHP Annual Meeting

    Application of Combined Reporting of Benefit and Harm (OMERACT 3×3 methodology) to the Rheumatoid Arthritis Comparison of Active Therapies Trial

    Maarten Boers1,2, Sarah Leatherman3, James R. O'Dell4 and Jeffrey R. Curtis5, 1Rheumatology, Amsterdam Rheumatology and immunology Center, VU University medical center, Amsterdam, Netherlands, 2Amsterdam Rheumatology and immunology Center, VU University Medical Center, Amsterdam, Netherlands, 3MAVERIC CSPCC (151MAV), VA Boston Healthcare System, Boston, MA, 4University of Nebraska Medical Center, Omaha, NE, 5Birmingham VAMC, Birmingham, AL

    Background/Purpose: The Outcome Measures in Rheumatology (OMERACT) Initiative has suggested an analysis of the occurrence of benefit and harm in trials simultaneously, at the individual…
  • Abstract Number: 2168 • 2015 ACR/ARHP Annual Meeting

    The Smoking Paradox in the Development of Myocardial Infarction Among Rheumatoid Arthritis Patients

    Uyen Sa D.T. Nguyen1, Yuqing Zhang2, Na Lu3, Jingbo Niu4, David T. Felson4, Michael P. Lavalley5, Jeffrey A. Sparks6, Shun-Chiao Chang7, Elizabeth W. Karlson8 and Hyon K. Choi3, 1Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 2Clinical Epidemilogy and Training Unit, Boston University School of Medicine, Boston, MA, 3Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 5Biostatistics, Boston University, Boston, MA, 6Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, 7Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 8Rheumatology, Brigham & Women's Hospital, Boston, MA

    Background/Purpose: Smoking is a strong risk factor for myocardial infarction (MI), but not among rheumatoid arthritis (RA) patients. These paradoxical findings may be due to…
  • Abstract Number: 2169 • 2015 ACR/ARHP Annual Meeting

    Low Education Is Associated with Mortality Among Individuals with Knee and/or Hip OA: The Johnston County Osteoarthritis Project

    Rebecca J. Cleveland1, Todd A. Schwartz2, Jordan B. Renner3, Joanne M. Jordan4 and Leigh F. Callahan4, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2School of Nursing, University of North Carolina, Chapel Hill, NC, 3Radiology, University of North Carolina, Chapel Hill, NC, 4Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC

    Background/Purpose: Low socioeconomic status (SES) is associated with an increased risk of death as well as knee and/or hip osteoarthritis (OA). SES and mortality has…
  • Abstract Number: 2170 • 2015 ACR/ARHP Annual Meeting

    Sleep Efficiency and Cardiovascular Risk Burden in Rheumatoid Arthritis

    Samannaaz S. Khoja1, Gustavo J. Almeida2, Mary Chester M. Wasko3 and Sara R. Piva2, 1Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 2Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 3Lupus Center, Pittsburgh, PA

    Background/Purpose: Sleep is an important physiological process responsible for regulating several metabolic and hormonal processes; hence, poor sleep may negatively impact health. Reduced sleep duration…
  • Abstract Number: 2171 • 2015 ACR/ARHP Annual Meeting

    A Comparison of Maternal Outcomes in Women with and without Juvenile Idiopathic Arthritis

    Debbie Ehrmann Feldman1, Sasha Bernatsky2, Evelyne Vinet3, Ciarán M. Duffy4, Elizabeth Hazel5, Garbis Meshefedjian6, Marie-Pierre Sylvestre7 and Anick Bérard1, 1Université de Montréal, Montréal, QC, Canada, 2Rheum/Clin. Epid., McGill MUHC/RVH, Montreal, QC, Canada, 3McGill University Health Centre, Montreal, QC, Canada, 4Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 5Rhematology, McGill University Health Centre, Montreal, QC, Canada, 6Public Health Department of Montreal, Montreal, QC, Canada, 7Université de Montréal, Montreal, QC, Canada

    Background/Purpose: Although there is a higher frequency of adverse maternal outcomes in mother with rheumatoid arthritis, little is known regarding mothers with juvenile idiopathic arthritis…
  • Abstract Number: 2172 • 2015 ACR/ARHP Annual Meeting

    Distribution of Clinical Osteoarthritis and Associations to Health-Related Quality of Life in a Population-Based Osteoarthritis Cohort

    Guro Økelsrud Lombnæs1, Karin Magnusson2 and Kåre Birger Hagen1, 1National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Department of Rheumatology, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: Osteoarthritis (OA) is a major cause of musculoskeletal pain and disability, and is commonly reported to impair health-related quality of life (HRQoL). We aimed…
  • Abstract Number: 2173 • 2015 ACR/ARHP Annual Meeting

    Impact of Smoking on Patient-Reported Disease Status and Symptoms Among Women with Lupus

    Patricia P. Katz1, Eliza Chakravarty2, Robert S. Katz3 and Kaleb Michaud4, 1Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Rush University Medical Center, Chicago, IL, 4Internal Medicine, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose:  Smoking appears to be associated both with an increased risk of rheumatoid arthritis and with more severe symptoms.  The impact of smoking on patient-reported…
  • Abstract Number: 2174 • 2015 ACR/ARHP Annual Meeting

    Neutrophils in Primary Antiphospholipid Syndrome Are Characterized By a Prominent Activated Phenotype and Uniquely Remodeled Chromatin Architecture

    Patrick Coit, Srilakshmi Yalavarthi, Jason S. Knight and Amr H. Sawalha, Division of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by recurrent thrombotic events, pregnancy complications, and the presence of antiphospholipid antibodies. The pathogenesis of…
  • « Previous Page
  • 1
  • …
  • 1831
  • 1832
  • 1833
  • 1834
  • 1835
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology